rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack
- RxCUI
- 1360632
- RxNorm name
- rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack
- Display name
- rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack
- Full name
- rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack
- Term type
- PSN
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:08
UNII Substances#
No records found.
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 939e28c5-f3a9-42c0-9a2d-8d471d82a6e0 | {7 (24 HR rotigotine 0.0833 MG/HR Transdermal System) / 7 (24 HR rotigotine 0.167 MG/HR Transdermal System) } Pack [GPCK] · rotigotine 2 MG/Day 24HR Transdermal System (7) / rotigotine 4 MG/Day 24HR Transdermal System (7) Pack [PSN] | 2 | 20 | These highlights do not include all the information needed to use NEUPRO safely and effectively. See full prescribing information for NEUPRO. NEUPRO (rotigotine transdermal system) Initial U.S. Approval: 2007 | 20250624 |